Towards Healthcare

Home Respiratory Monitor Market Strategic Recommendations for Industry Leaders

Based on our market research, the home respiratory monitor market was valued at USD 2.55 billion in 2025 and is projected to reach USD 2.78 billion in 2026, further expanding to USD 6.12 billion by 2035 at a CAGR of 9.15% during 2026–2035.

Last Updated : 20 February 2026 Category: Medical Devices Insight Code: 6699 Format: PDF / PPT / Excel
Revenue, 2025
USD 2.55 Billion
Forecast, 2035
USD 6.12 Billion
CAGR, 2026-2035
9.15%
Report Coverage
Global

The global home respiratory monitor market size was estimated at USD 2.55 billion in 2025 and is predicted to increase from USD 2.78 billion in 2026 to approximately USD 6.12 billion by 2035, expanding at a CAGR of 9.15% from 2026 to 2035.

Home Respiratory Monitor Market Trends and Growth (2026)

Day by day, the globe is facing a huge rise in COPD and asthma cases, which are demanding more sophisticated respiratory devices. Whereas leading firms are fostering the development of portable solutions, with the use of AI-enhanced approaches.

Key Takeaways

  • Home respiratory monitor market to crossed USD 2.78 billion by 2026.
  • Market projected at USD 6.12 billion by 2035.
  • CAGR of 9.15% expected in between 2026 to 2035.
  • North America accounted for nearly 44.1% share of the home respiratory monitor market in 2025.
  • Asia Pacific is expected to grow at an approximate 10.2% CAGR in the upcoming years.
  • By product type, the pulse oximeters segment led with approximately 38.5% revenue share of the market in 2025.
  • By product type, the smart inhalers segment is expected to witness rapid expansion in the studied years.
  • By indication, the COPD segment captured an approximate 42.2% share of the market in 2025.
  • By indication, the asthma segment is expected to grow at the fastest CAGR during 2026-2035.
  • By technology, the portable/handheld segment held a major share of nearly 62.0% of the market in 2025.
  • By technology, the wearable segment is expected to grow at the fastest CAGR during the forecast period.

What are the Extensive Dynamics in the Home Respiratory Monitor?

Primarily, the home respiratory monitor market has shifted from "clinical-only" use to a remote patient monitoring (RPM) standard, and this has been majorly fueled by the "Hospital-at-Home" movement. However, home respiratory monitors are now combined with AI-powered analytics that predict exacerbations in COPD and Asthma patients up to 48 hours before they occur. Moreover, the market has been transforming medical-grade wearable biosensors and patches to track respiratory rate & blood oxygen consistently.

What are the Emerging AI Breakthroughs in the Home Respiratory Monitor Market?

A foremost step by leading companies is a greater emphasis on the development of non-contact sensing, smartphone-based diagnostics, and AI-assisted smart inhalers to manage conditions such as COPD, asthma, & sleep apnea. For example, the APNEAL App is a smartphone-based device that meets FDA/CE requirements and uses phone sensors, like an accelerometer, gyroscope, and microphone, to determine sleep apnea. Whereas the EU RESPIRE project explored a 34% reduction in asthma-related hospitalizations by utilizing machine learning models.

Pushing IoT & Perfect Connectivity

The globe has demonstrated that nearly 75% of devices are predicted to have smart connectivity, conveying data directly to providers for real-time monitoring, which enhances medication adherence by up to 50%.

Promotion of Multimodal Sensing

Firms are emphasizing a combination of sensors to record chest and abdominal movements, i.e. dual breathing belts, to grab the entire data on breathing mechanics.

Fostering FMCW Radar-Based Systems

Researchers are investigating Frequency-Modulated Continuous-Wave (FMCW) radar to track respiration rates & patterns in infants and adults without any requirement of skin contact.

Key Indicators and Highlights

Key Elements Scope
Market Size in 2026 USD 2.78 Billion
Projected Market Size in 2035 USD 6.12 Billion
CAGR (2026 - 2035) 9.15%
Leading Region North America by 44.1%
Market Segmentation By Product Type, By Indication, By Technology, By Region
Top Key Players ResMed Inc., Koninklijke Philips N.V., Medtronic plc, Masimo Corporation, Fisher & Paykel Healthcare, GE HealthCare, Propeller Health, Teva Pharmaceuticals (Digihaler), Vyaire Medical, Smiths Medical (ICU Medical)

Segmentation Analysis

Product Type Insights

Which Product Type Led the Home Respiratory Monitor Market in 2025?

In 2025, the pulse oximeters segment held nearly 38.5% share of the market. This is driven by its crucial, non-invasive, & instant measurements of blood oxygen saturation and heart rate, which allow for early detection of hypoxemia and monitoring of chronic issues, including COPD, asthma, and COVID-19. Ongoing efforts are focusing on designing devices for persistent, overnight, or long-term monitoring to detect silent hypoxia. Zynex Medical NiCO employs laser technology to record four hemoglobin species for rigorous detection of hypoxia and hyperoxia.

Smart Inhalers

The smart inhalers segment is expected to grow at the fastest CAGR. Globally accelerating cases of asthma and COPD require consistent, long-term monitoring & optimized, accurate drug delivery, which is fueling demand for these inhalers. These devices are highly utilizing machine learning to assess inhaler usage patterns and anticipate asthma or COPD attacks up to five days in advance.

Indication Insights

How did the COPD Segment Dominate the Market in 2025?

The COPD segment led with approximately 42.2% share of the home respiratory monitor market in 2025. As per a study, in 2025, there will be nearly 480 million cases of COPD across the world, which demands continuous, at-home, or affordable management of chronic exacerbations. Inogen Rove 6, Philips EverGo AI+, & CAIRE FreeStyle Comfort Smart are substantial, featuring adaptive algorithms that assist in adjusting oxygen flow based on movement & oxygen saturation (SpO₂) levels.

Asthma

The asthma segment is estimated to expand at a rapid CAGR during 2026-2035. A recent research study has shown the adoption of Respiratory-Responsive Vocal Biomarkers (RRVB) to find real-time changes in respiratory state & asthma exacerbations using smartphone apps. However, ADAMM (Automated Device for Asthma Monitoring and Management) also support tracking of cough, breathing patterns, heart rate, & temperature to facilitate tailored asthma management feedback.

% Rise in Asthma New Cases by 2030 (Approx.)

Technology Insights

Which Technology Led the Home Respiratory Monitor Market in 2025?

The portable/handheld segment captured an approximate 62.0% share of the market in 2025. This is mainly propelled by their daily monitoring of lung health, which enables early detection of changes in chronic concerns, such as COPD, asthma, and post-COVID recovery. Philips Respironics is one of the robust and sophisticated portable ventilators, which features AI-driven respiratory pattern detection, focused on escalating remote monitoring for both clinical and home use.

Wearable

Moreover, the wearable segment is predicted to expand at the highest CAGR during the forecast period. This mainly offers continuous, non-invasive monitoring of breathing patterns, lung sounds, and oxygen levels, which enable early detection of respiratory issues. A major transformation includes wearable, paper-based, & electrochemical sensors, like using polyaniline/Prussian blue nanolayers that are directly united into face masks to monitor hydrogen peroxide levels in exhaled breath.

Regional Insights

Home Respiratory Monitor Market Share, By Region, 2025 (%)

What Made North America Dominant in the Market in 2025?

With an approximate 44.1% share, North America registered dominance in the home respiratory monitor in 2025. The regional growth is propelled by a rise in the prevalence of asthma (25M+ Americans) & an advanced Medicare reimbursement structure for Remote Physiological Monitoring (RPM) & Remote Therapeutic Monitoring (RTM). Whereas, the Sleepiz One+ secured FDA approval for use in the US as a contactless, bedside device for monitoring breathing rates and heart rates, & it is a "wired-to-wireless" shift for home monitoring.

U.S. Market Trends

The U.S. held a major share of the market, as it focused on exploring AI-assisted diagnostics. TytoCare broadened the use of Tyto Insights for Wheeze Detection by employing AI in the analysis of lung sounds from a home stethoscope. Alongside, Makani Science acquired FDA 510(k) clearance for a wearable, non-invasive monitor to facilitate continuous, real-time respiratory data.

Chronic Respiratory Concerns & Non-Contact Solutions are Driving the Asia Pacific

 Asia Pacific is anticipated to witness rapid growth of approximately 10.2% in the home respiratory monitor market due to the rising instances of respiratory conditions, especially in China & India. Whereas Japan is emphasizing the progression of eldercare, non-contact monitoring, including Nemuri SCAN, a bed-placed sensor to record heart rate, respiratory rate, and body movements during sleep.

India Market Trends

India is promoting connected smart respiratory devices, which explore IoT-enabled solutions to enable data transmission directly to smartphones and healthcare providers. The latest advancement comprises Lupin Adhero, which is connected to a Metered Dose Inhaler (MDI) to monitor medication usage patterns.

Home Respiratory Monitor Market- Value Chain Analysis

R&D

  • This covers a multidisciplinary approach, which integrates biomedical engineering, sensor technology, data science, and user-centric design to evolve devices for tracking breathing rates, patterns, or lung function outside clinical settings.
  • Key Players: Koninklijke Philips N.V., ResMed Inc., Medtronic plc, etc.

Clinical Trials & Regulatory Approvals

  • Diverse devices from wearable acoustic sensors to contactless radar technology need robust clinical validation against the gold standard in-clinic approaches, including capnography, to secure regulatory clearance.
  • Key Players: Assistance Publique - Hôpitaux de Paris, Movano Health, Acurable Ltd., etc.

Patient Support & Services

  • Many programs are featuring professional, precision care from clinicians who review data, provide, install, and maintain equipment, & provide 24-hour support to lower hospitalizations.
  • Key Players: Accuhealth, OXIGEN Salud, ChronicCareIQ, etc.

Key Players' Offerings in the Home Respiratory Monitor Market

Home Respiratory Monitor Market Key Players

Company Description
ResMed Inc. This offers solutions that integrate medical devices with cloud-based software.
Koninklijke Philips N.V. A firm explores solutions through its Philips Respironics brand and also facilitates diverse home respiratory monitoring & therapy solutions. 
Medtronic plc This usually focuses on continuous, non-invasive, and remote patient monitoring, especially through their Nellcor & Microstream product lines.
Masimo Corporation A company executing its proprietary Signal Extraction Technology (SET).
Fisher & Paykel Healthcare This emphasizes humidification and respiratory support devices. 
GE HealthCare Their offerings include advanced hospital-grade systems and combined remote patient monitoring (RPM) solutions.
Propeller Health It offers a digital respiratory health platform using connected inhaler sensors & software to track and manage asthma and COPD from home
Teva Pharmaceuticals (Digihaler) A company facilitates a series of FDA-cleared, Bluetooth-connected, breath-activated dry powder inhalers.
Vyaire Medical It explores various portable, handheld devices for diagnostic, monitoring, & therapeutic use in homes, clinics, and during transport.
Smiths Medical (ICU Medical) This usually promotes many home respiratory care products focused on bronchial hygiene, lung expansion, & tracheostomy care.

SWOT Analysis

Strengths

  • These devices significantly offer 24/7 or 24-hour tracking and enable the detection of sudden changes in breathing patterns or oxygen saturation.
  • Alongside, they lower the burden of travel, minimize the risk of contamination, and raises quality of life for patients with chronic conditions, such as COPD, asthma, or those in post-COVID-19 recovery.

Weaknesses

  • Specifically, wearable chest belts or patches are highly prone to noise and artifacts from daily activities, movement, coughing, or talking, which leads to inaccurate respiration rate (RR) readings.
  • Certain home cardiorespiratory monitors have not been proven to lower the risk of Sudden Infant Death Syndrome (SIDS).

Opportunities

  • Prospective wearables may encompass sensors for monitoring indoor/outdoor air quality to support asthma patients in avoiding irritants & allergens.
  • Devices will facilitate objective data on lung function during daily life, which enhances management of chronic conditions, including cystic fibrosis and interstitial lung disease.

Threats

  • The emergence of inaccurate, unreliable, or misused devices can result in false-positive or false-negative results.
  • Higher expenditure on devices and consumables can limit adoption.

What are the Key Developments in the Home Respiratory Monitor Market?

  • In November 2025, SoundHealth launched Spatial Sleep, a customized acoustic sleep headband to assist people in falling asleep faster, sleeping longer and waking up refreshed.
  • In September 2025, electronRx launched the pDx App for remote chronic respiratory disease management.
  • In August 2025, Nonin Medical unveiled the Nonin Health platform, a cloud-based data ecosystem and software platform for durable & home medical equipment (DME/HME) providers, sleep dentists, and sleep labs.

Segments Covered in the Report

By Product Type

  • Pulse Oximeters
  • Smart Inhalers
  • Spirometers & Peak Flow Meters
  • Sleep Apnea Monitors

By Indication

  • COPD
  • Asthma
  • Sleep Apnea

By Technology

  • Portable/Handheld
  • Wearable 

By Region

  • North America
    • U.S.
    • Canada 
    • Mexico 
    • Rest of North America
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe 
    • Western Europe 
      • Germany 
      • Italy
      • France
      • Netherlands
      • Spain
      • Portugal 
      • Belgium
      • Ireland
      • UK 
      • Iceland 
      • Switzerland
      • Poland
      • Rest of Western Europe
    • Eastern Europe 
      • Austria
      • Russia & Belarus 
      • Türkiye
      • Albania 
      • Rest of Eastern Europe 
  • Asia Pacific
    • China 
    • Taiwan
    • India 
    • Japan 
    • Australia and New Zealand
    • ASEAN Countries (Singapore, Malaysia)
    • South Korea 
    • Rest of APAC 
  • MEA 
    • GCC Countries
      • Saudi Arabia 
      • United Arab Emirates (UAE)
      • Qatar 
      • Kuwait 
      • Oman 
      • Bahrain 
    • South Africa
    • Egypt 
    • Rest of MEA

FAQ's

Finding : The home respiratory monitor market stands at USD 2.78 billion in 2026 and is expected to reach USD 6.12 billion by 2035, growing at a CAGR of 9.15% from 2026 to 2035.

Finding : North America is currently leading the home respiratory monitor market by 44.1% due to the increasing cases of asthma & a well-developed Medicare reimbursement landscape. 

Finding : NIH, US FDA, EPA, ClinicalTrials.gov, NHS, DST, CDC, WHO, etc.

Tags

Meet the Team

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and strategy.

Learn more about Shivani Zoting

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar

Related Reports

Home Respiratory Monitor Market
Updated Date: 20 February 2026   |   Report Code: 6699